3-Aminopperidine-2,6-Dion Hydrochloride CAS 24666-56-6;2686-86-4 Tsafta > 99.0% Lenalidomide Tsakanin Masana'antu
Ruifu Chemical shine babban masana'anta na 3-Aminopperidine-2,6-Dion Hydrochloride (CAS: 24666-56-6; 2686-86-4) tare da babban inganci, matsakaici na Pomalidomide (CAS: 19171-19-8).Ruifu Chemical na iya samar da isar da saƙo na duniya, farashi mai gasa, kyakkyawan sabis, ƙanana da adadi mai yawa akwai.Sayi 3-Aminopperidine-2,6-Dion Hydrochloride, Please contact: alvin@ruifuchem.com
| Sunan Sinadari | 3-Aminopperidine-2,6-Dion Hydrochloride |
| Makamantu | 3-Aminopperidine-2,6-Dion HCl;3-Amino-2,6-Piperidinedione Hydrochloride;2,6-Dioxopiperidine-3-Ammonium chloride |
| Lambar CAS | 24666-56-6 |
| CAS mai alaƙa | 2686-86-4;25181-50-4 |
| Matsayin Hannun jari | A cikin Hannun jari, Ma'aunin samarwa Har zuwa Ton |
| Tsarin kwayoyin halitta | Saukewa: C5H9ClN2O2 |
| Nauyin Kwayoyin Halitta | 164.59 |
| Matsayin narkewa | 120 ℃ |
| COA & MSDS | Akwai |
| Asalin | Shanghai, China |
| Alamar | Ruifu Chemical |
| Abu | Ƙayyadaddun bayanai |
| Bayyanar | Kashe-White Crystalline Foda |
| Tsarkake / Hanyar Bincike | > 99.0% (HPLC) |
| Danshi (KF) | <0.50% |
| Asara akan bushewa | <0.50% |
| Ragowa akan Ignition | <0.20% |
| Jimlar ƙazanta | <1.00% |
| Infrared Spectrum | Yayi daidai da Tsarin |
| Matsayin Gwaji | Matsayin Kasuwanci |
| Amfani | Matsakaicin Lenalidomide (CAS: 191732-72-6) |
Kunshin: Bottle, Aluminum tsare jakar, 25kg / kwali Drum, ko bisa ga abokin ciniki ta bukata
Yanayin Ajiya:Ajiye a cikin kwantena da aka rufe a wuri mai sanyi da bushe;Kare daga haske da danshi
3-Aminopperidine-2,6-Dion Hydrochloride (CAS: 24666-56-6; 2686-86-4) shine matsakaici don shirya Lenalidomide (CAS: 191732-72-6).Lenalidomide wani nau'in magungunan kashe kwayoyin cuta ne wanda kamfanonin harhada magunguna na Amurka suka kirkira.Yana da ayyuka da yawa kamar anti-tumor, tsarin rigakafi da anti-angiogenesis.Yana iya hana fitowar cytokines masu kumburi, kuma yana ƙara fitowar cytokines na anti-mai kumburin jini mononuclear.Yana iya hana haɓakar ƙwayoyin myeloma da yawa na marasa lafiya da tantanin halitta MM1S.Biyu da yawa makafi bazuwar nazarin asibiti mai sarrafa wuribo-makafi suna kimanta aminci da tasirin warkarwa na lenalidomide wanda ake amfani da shi don myeloma da yawa.Sakamakon bincike na asibiti na baya-bayan nan ya nuna cewa lenalidomide ba wai kawai yana da tasirin warkewa akan maganin MDS da MM ba, har ma a kan kula da myeloma, cutar sankarar bargo, carcinoma na renal cell metastatic, ƙwayar cuta mai ƙarfi, amyloidosis na idiopathic gabaɗaya da cututtukan fibrosis na kasusuwa tare da marrow unripe.A cikin Disamba 2005, Hukumar Abinci da Magunguna ta Amurka (FDA) ta amince da lenalidomide da za a yi amfani da shi wajen maganin ciwon myelodysplastic (MDS).
